Evidence map›Paper›PMID 33585788›Full record

ArticleTH open : companion journal to thrombosis and haemostasis2021

Inferior Vena Cava Filter Retrieval Trends: A Single-Center Experience.

Filip Ionescu, Nwabundo Anusim, Eva Ma, Lihua Qu, LeAnn M Blankenship, Michael Stender, Ishmael Jaiyesimi

Open access · goldAbstract read
In one paragraph

Article in TH open : companion journal to thrombosis and haemostasis, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Predictors of retrieval and long-term mortality in patients treated with inferior vena cava filters.Journal of vascular surgery. Venous and lymphatic disorders · 2024
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Filip IonescuDepartment of Internal Medicine, Beaumont Health System, Royal Oak, Michigan, United States.ORCID 0000-0003-3097-8985
Nwabundo AnusimDepartment of Hematology-Oncology, Beaumont Health System, Royal Oak, Michigan, United States.
Eva MaDepartment of Internal Medicine, Beaumont Health System, Royal Oak, Michigan, United States.
Lihua QuBeaumont Health Research Institute, Royal Oak, Michigan, United States.
LeAnn M BlankenshipDepartment of Hematology-Oncology, Beaumont Health System, Royal Oak, Michigan, United States.
Michael StenderDepartment of Hematology-Oncology, Beaumont Health System, Royal Oak, Michigan, United States.
Ishmael JaiyesimiDepartment of Hematology-Oncology, Beaumont Health System, Royal Oak, Michigan, United States.
Beaumont Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recognition of the adverse events of inferior vena cava filters (VCFs) has prompted the Food and Drug Administration (FDA) to issue safety warnings (2010 and 2014), advocating for removal, once the risk of pulmonary embolism has abated. Despite an initial increase in retrieval rates, these remain low (25-30% at 1 year in 2014). We retrospectively investigated retrieval trends in adults with VCFs placed between 2015 and 2018 at a single institution. The rate of retrievable VCF removal accounting for the competing risk of death was the main outcome. There were 494 VCFs placed (305 retrievable). The cumulative incidence of retrieval remained low (21% at 1 year), even after the second FDA warning (2014). Patients who resumed anticoagulation (AC) at any time were more likely to have retrieval (hazard ratio [HR] = 3.6,

Indexed as

filter failureIVC filterpractice trendsretrievalthrombosis

Identifiers

PMID33585788
PMCPMC7875678
OpenAlexW3131511710

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.